Skin-on-a-Chip Technology for Testing Transdermal Drug Delivery—Starting Points and Recent Developments

During the last decades, several technologies were developed for testing drug delivery through the dermal barrier. Investigation of drug penetration across the skin can be important in topical pharmaceutical formulations and also in cosmeto-science. The state-of- the-art in the field of skin diffusi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zsófia Varga-Medveczky, Dorottya Kocsis, Márton Bese Naszlady, Katalin Fónagy, Franciska Erdő
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/034933ad392b4da3a7af029e4e7ab666
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:034933ad392b4da3a7af029e4e7ab666
record_format dspace
spelling oai:doaj.org-article:034933ad392b4da3a7af029e4e7ab6662021-11-25T18:41:09ZSkin-on-a-Chip Technology for Testing Transdermal Drug Delivery—Starting Points and Recent Developments10.3390/pharmaceutics131118521999-4923https://doaj.org/article/034933ad392b4da3a7af029e4e7ab6662021-11-01T00:00:00Zhttps://www.mdpi.com/1999-4923/13/11/1852https://doaj.org/toc/1999-4923During the last decades, several technologies were developed for testing drug delivery through the dermal barrier. Investigation of drug penetration across the skin can be important in topical pharmaceutical formulations and also in cosmeto-science. The state-of- the-art in the field of skin diffusion measurements, different devices, and diffusion platforms used, are summarized in the introductory part of this review. Then the methodologies applied at Pázmány Péter Catholic University are shown in detail. The main testing platforms (Franz diffusion cells, skin-on-a-chip devices) and the major scientific projects (P-glycoprotein interaction in the skin; new skin equivalents for diffusion purposes) are also presented in one section. The main achievements of our research are briefly summarized: (1) new skin-on-a-chip microfluidic devices were validated as tools for drug penetration studies for the skin; (2) P-glycoprotein transport has an absorptive orientation in the skin; (3) skin samples cannot be used for transporter interaction studies after freezing and thawing; (4) penetration of hydrophilic model drugs is lower in aged than in young skin; (5) mechanical sensitization is needed for excised rodent and pig skins for drug absorption measurements. Our validated skin-on-a-chip platform is available for other research groups to use for testing and for utilizing it for different purposes.Zsófia Varga-MedveczkyDorottya KocsisMárton Bese NaszladyKatalin FónagyFranciska ErdőMDPI AGarticletopical drug diffusionskin-on-a-chipmicrofluidicsFranz diffusion cellsskin equivalentsdrug deliveryPharmacy and materia medicaRS1-441ENPharmaceutics, Vol 13, Iss 1852, p 1852 (2021)
institution DOAJ
collection DOAJ
language EN
topic topical drug diffusion
skin-on-a-chip
microfluidics
Franz diffusion cells
skin equivalents
drug delivery
Pharmacy and materia medica
RS1-441
spellingShingle topical drug diffusion
skin-on-a-chip
microfluidics
Franz diffusion cells
skin equivalents
drug delivery
Pharmacy and materia medica
RS1-441
Zsófia Varga-Medveczky
Dorottya Kocsis
Márton Bese Naszlady
Katalin Fónagy
Franciska Erdő
Skin-on-a-Chip Technology for Testing Transdermal Drug Delivery—Starting Points and Recent Developments
description During the last decades, several technologies were developed for testing drug delivery through the dermal barrier. Investigation of drug penetration across the skin can be important in topical pharmaceutical formulations and also in cosmeto-science. The state-of- the-art in the field of skin diffusion measurements, different devices, and diffusion platforms used, are summarized in the introductory part of this review. Then the methodologies applied at Pázmány Péter Catholic University are shown in detail. The main testing platforms (Franz diffusion cells, skin-on-a-chip devices) and the major scientific projects (P-glycoprotein interaction in the skin; new skin equivalents for diffusion purposes) are also presented in one section. The main achievements of our research are briefly summarized: (1) new skin-on-a-chip microfluidic devices were validated as tools for drug penetration studies for the skin; (2) P-glycoprotein transport has an absorptive orientation in the skin; (3) skin samples cannot be used for transporter interaction studies after freezing and thawing; (4) penetration of hydrophilic model drugs is lower in aged than in young skin; (5) mechanical sensitization is needed for excised rodent and pig skins for drug absorption measurements. Our validated skin-on-a-chip platform is available for other research groups to use for testing and for utilizing it for different purposes.
format article
author Zsófia Varga-Medveczky
Dorottya Kocsis
Márton Bese Naszlady
Katalin Fónagy
Franciska Erdő
author_facet Zsófia Varga-Medveczky
Dorottya Kocsis
Márton Bese Naszlady
Katalin Fónagy
Franciska Erdő
author_sort Zsófia Varga-Medveczky
title Skin-on-a-Chip Technology for Testing Transdermal Drug Delivery—Starting Points and Recent Developments
title_short Skin-on-a-Chip Technology for Testing Transdermal Drug Delivery—Starting Points and Recent Developments
title_full Skin-on-a-Chip Technology for Testing Transdermal Drug Delivery—Starting Points and Recent Developments
title_fullStr Skin-on-a-Chip Technology for Testing Transdermal Drug Delivery—Starting Points and Recent Developments
title_full_unstemmed Skin-on-a-Chip Technology for Testing Transdermal Drug Delivery—Starting Points and Recent Developments
title_sort skin-on-a-chip technology for testing transdermal drug delivery—starting points and recent developments
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/034933ad392b4da3a7af029e4e7ab666
work_keys_str_mv AT zsofiavargamedveczky skinonachiptechnologyfortestingtransdermaldrugdeliverystartingpointsandrecentdevelopments
AT dorottyakocsis skinonachiptechnologyfortestingtransdermaldrugdeliverystartingpointsandrecentdevelopments
AT martonbesenaszlady skinonachiptechnologyfortestingtransdermaldrugdeliverystartingpointsandrecentdevelopments
AT katalinfonagy skinonachiptechnologyfortestingtransdermaldrugdeliverystartingpointsandrecentdevelopments
AT franciskaerdo skinonachiptechnologyfortestingtransdermaldrugdeliverystartingpointsandrecentdevelopments
_version_ 1718410753359216640